THE SHOCKING TRUTH ABOUT BMSN 90% of all start

New Post Public Reply Private Reply Replies (0) Message Board
DarkKnight83

[b]THE SHOCKING TRUTH ABOUT BMSN[/b]

90% of all start up companies biotech or not reports -O- income. Why would they have a revenue stream with no product? Once they have a marketable FDA

approved product then they can attract big pharma to buy them out! I never heard of any start-up penny stock company making millions of dollars in

revenue with no product! There will be a drastic change in PPS this July as FDA response is expected to come any day now that will initiate clinical

trials on humans.

Click on the link below to see why biotech companies need to dilute and what operating expenses they have?

http://www.dataev.com/it-experts-blog/bid/290...kimp-on-IT

Lawsuits? All BMSN Lawsuit have been [b]resolved[/b]! Case close! [b]Not[/b] wanted for federal questioning! Those lawsuit were meaningless! C'mon a

shell company that has no asset's nor product try's to cash in on BMSN!! Lawsuits happen all the time in every company! Not all claims are legit!

Look at StarCity capital LLC. with no [b]executives or employees[/b]! BWhahahahahahaha!! StarCity capital was just looking for a quick payday!! Its

equilavent to some sueing Mcdonalds for coffee that's too hot when they clearly ordered hot coffee!! lmao

http://investing.businessweek.com/research/st...=222502242

(Most Recent- Settled) Lawsuit Filed April 12, 2013

1. On January 2, 2013, Starcity exercised its right to convert $17,000 of its debt into

103,030,303 shares of BMSN (the “Conversion Notice”). The Conversion Notice took

advantage of extraordinarily low public market prices of BMSN common stock, as was Starcity’s

right under the STA. The next day, on January 3, 2013, Defendants, as they were required to do,

Between January 2, 2013 and February 27, 2013, Defendants, with the intent to

prefer their own personal and other stockholders’ stock positions ahead of Starcity’s lawful

stockholder position in BMSN, and to the knowing detriment of Starcity, used false promises and

deception to trick Starcity into surrendering its Starcity BMSN Stock Certificate based on the

false promise that such shares promptly would be transmitted electronically to Starcity’s

brokerage account via DWAC. For weeks after Starcity surrendered its Starcity BMSN Stock

Certificate, and while the price of BMSN stock was trading at similar very low prices,

Defendants continuously and falsely reassured Starcity that such DWACtransmission would be

made promptly. All the while, Defendants, and each of them, knew that Defendants intended to

construe the surrendering of such Starcity ...ons ahead of Starcity’s lawful

stockholder position in BMSN.

NOW THAT THESE Starcity FOOLS SOLD ALL THEIR BMSN TICKETS UP WE GO! THAT WAS THE LAST LAWSUIT WHICH HAS BEEN RESOLVED!!

Here are the other two which OLD and RESOLVED!!!

2. SETTLEMENT AGREEMENT

Parties: BIO-MATRIX SCIENTIFIC GROUP, INC. | 18 KTTV, LLC | BIO-MATRIX SCIENTIFIC GROUP, INC

Document Date: 3/12/2013

Industry: Medical Equipment and Supplies

Sector: Healthcare

Governing Law ennsylvania

3. SETTLEMENT AGREEMENT

Parties: ENTEST BIOMEDICAL, INC. | 18 KTTV, LLC | ENTEST BIOMEDICAL, INC

Document Date: 3/12/2013

Industry: Biotechnology and Drugs

Sector: Healthcare

Governing Law ennsylvania

10K spells out lawsuit resolution in section 11

THESE LAWSUITS ARE SO BORING AND IRREVELANT TO FDA APPROVAL! EVERY COMPANY WITH A LEGIMATE SERVICE OR PRODUCT IS EXPOSED TO LAWSUITS! BIG DEAL!!

CASE RESOLVED!! IN ADDITION THEY ARE ALL OLD! YAWN!!

CLICK ON THE LINK BELOW!! [b]ALL LAWSUIT ARE RESOLVED!![/b] LOOK ON THE BOTTOM 8 & 9!!

http://agreements.realdealdocs.com/Settlement-Agreement/

CLICK ON THE LINK BELOW TO FIND OUT WHY [b]DILUTION ISN"T ALWAYS A BAD THING[/b]!!

http://blog.seedrs.com/2013/06/14/why-dilutio...bad-thing/

http://www.dummies.com/how-to/content/new-pen...r-bad.html

[b]When new penny stock share issues are a good thing:[/b]

Legal battles: Smaller companies often find themselves in costly legal battles with much bigger players. For example, many tech companies must go to

court to enforce patents rights. To pay legal fees, companies may issue shares for general working capital purposes. When the company is on the right

side of a legal battle, it can be beneficial for them and shareholders to dilute in order to litigate.

The O/S is maxed out!! Dilution is over!

Here is an example of Oustanding shares and its impact!

Comparison of stocks - shares outstanding:

Intel (INTC) -      5.52 billion shares outstanding

Texas Instruments (TXN) -   1.24 billion shares outstanding (23% of Intel's # of shares)

Analog Devices (ADI) -      297.69 million shares outstanding (5% of Intel)

STMicroelectronics (STM) -      878.32 million shares outstanding (16% of Intel)

Advanced Micro Devices (AMD) -      672.13 million shares outstanding (12% of Intel)

Share stability and volatility:  A greater number of shares outstanding can also support the claim that a company has greater price stability, given

that it takes many more shares traded to create a significant percentage movement in the stock.  Contrary to this, the stock with a much lower number of

outstanding shares, like ADI above, representing only 5% of Intel's total, could be more vulnerable to price manipulation, requiring much fewer shares

to be traded up or down to move the stock price.

These BMSN Short Numbers are ridiculous

http://otcshortreport.com/index.php?index=BMSN

http://www.shortanalytics.com/getshortchart.php?tsymbol=BMSN

Good evening!! BMSN Crew!! BMSN has accomplished so much and has even been featured on NBC NEWS!! Know what you hold! There is plenty of DD out there!

These shares are more precious than gold right now! Treat it as such and enjoy the ride north!! We have a strong chance of hitting .007 today!!

http://www.nbcnews.com/id/51786808#.UZFZQIy9KSM

(Link is expired due to NBC featured news time frame)

Just because a company hired an outside source for more exposure doesn't make it a P&D scam!! eg. FB, FNMA

http://stockpromoters.com/view-stock-promotio...ceHolderyy

%24Footer1%24Image2.x=12&ctl00%24ContentPlaceHolderyy%24Footer1%24Image2.y=11

[i]

Get in now or miss the chance of a life time here!![/i]

Check out the technical chart analysis on BMSN! Clearly the charts are BULLISH!!

http://bullwarriorstocks.com/index.php/post/b...-6-14-2013

Oh Lawd look at this short volume!! I'm getting excited just thinking about the gains!! Please cover!

http://otcshortreport.com/index.php?index=BMSN

http://www.shortanalytics.com/getshortchart.php?tsymbol=BMSN

[b]Oncology Innovations[/b]

Some of biggest innovations have been in the field of oncology. The actress Angelina Jolie recently became the new face of breast cancer, after

announcing that she’d had a double-mastectomy upon discovering that she carried a gene that predicts about a 60 percent chance of developing the

disease.

Thanks to the advances in genetic screening, drug developers also now look for genetic mutations in tumors that can explain why they grow and

metastasize, and create drugs to specifically target that aspect of the disease.

Surely BMSN will save lives and eliminate the budden of a mastectomy! Breast cancer gene silicensing technology will do just that!!

Bio-Matrix Scientific Group's Regen BioPharma Submits Response to FDA Questions Regarding HemaXellerate Clinical Program

http://finance.yahoo.com/news/bio-matrix-scie...00616.html

Lets just say that the FDA has 30days to respond which I highly doubt it would take that long cause they already have BMSN information filed on their

system! We should be hearing a verdict by Mid July the latest! But realisticly a response from FDA can come with 2-3 weeks considering that the response

is mailed!

"We are pleased with the responses that we have provided to the FDA and look forward to initiating our clinical trials," stated David Koos, Chairman and

CEO of Regen BioPharma. "Although it is possible that a second round of comments may be issued, we feel this process is extremely useful to creating a

clinical trial that is optimized for safety and detection of efficacy."

http://finance.yahoo.com/news/bio-matrix-scie...00616.html

This is not a 1 day flip! If your looking for that please exit left! There are plenty of BS pump and dumps out there! BMSN is a long term hold! The

clock for FDA response started JUNE 7, 2013! They have [b]30 days[/b] to respond back! So I say mid July - August

we should here a final verdict! I haven't seen any recent dilution! Just a lot of stupid trading and heavy manipulation!

For people who kept complaining about the time for [b]IND submission time frame[/b] please click the link below and your faith in BMSN will be restored!

On Feb 5, 2013 Regen BioPharma Files Investigational New Drug (IND) Application With FDA on HemaXellerate I(TM) Stem Cell Drug for Aplastic Anemia!

http://www.ucdmc.ucdavis.edu/clinicaltrials/IND/step4.html

This link is proof that the application as MAIL rather Electronic submission! In the link it clearly states that the application must be mailed with 3

copies of the entire submission! Which mean Koos wasn't hiding information or delaying! It takes time to get the application processed, filed then

issued a reference number (IND#) Koos is operating with urgency not to please investors but to put BMSN on the right track to success!

Here the proof that [b]eliminates[/b] all doubt!! Copy and paste this text into a search engine! I used google! >>>>>>>investigational new drug (ind)

application process<<<<<<<

Next look for a PDF link from the FDA! It should be the Third box down! And the link should be something like this:

www.fda.gov/downloads/.../reportsmanualsforms/forms....

Ok now download the form yourself! Scroll to the bottom of the form! If clearly has signature panel boxes as well as the panel where a FDA official

would give the application an IND#!!!

IND# issuance is clearly not like buy a gallon a milk at the supermarket where a receipt is given immediately! The FDA submission process is very slow

for a reason! We are dealing with human life here! Have patience investors, sit back and accumulate those cheap shares while they are still here! [b]

Last major run we had only took 1 week to reach from sub-penny level to almost .02 cents!! That's how fast BMSN moves!! We will have our day in the sun!

[/b]

Now that we know for sure that we are operating in FISCAL year! Things will be very interesting in the next 30 days!! Not long before BMSN HemaXellerate

receives IND status!! My honest advice BUY and HOLD!! THESE PRICES ARE GIFTS!!

[b]FOURTH QUARTER [/b]STARTS IN JULY AND GUESS WHATS ON THE AGENDA!![b] BOOOMM [/b]TIME!!

Breast Cancer Technology NEWS was annouced in FEB. which mean BMSN business plan is in fiscal quarter NOT calender! This Breast Cancer news was FIRST

Press Release: Bio-Matrix Scientific Group Inc. – Tue, Feb 26, 2013 10:12 AM!!! Click on the link Below and do the math yourself! FDA news can arrive at

any moment! I can't believe people are confused on this issue! BMSN is not trying to confused investors! All the info is clearly laid out in black and

white!

WHY WOULD MMs ALLOW THE PPS TO RISE SO SUDDENLY THINK ABOUT IT!

http://finance.yahoo.com/news/bio-matrix-rege...30212.html

http://finance.yahoo.com/q/h?s=BMSN&t=201...2:12-04:00

FISCAL NOT CALENDER!!!

Upcoming Milestones

Response to FDA questions: Q3 2013

Initiate HemaXellerate trial: Q4 2013

Complete HemaXellerate trial: Q4 2014-Q2 2015

In license Min technology: Q2 2013

File IND on Min technology: Q4 2013

Initiate clinical trial on Min technology: Q4 2013

Complete clinical trial on Min technology: Q4 2014-Q2 2015

Q1= OCT NOV DEC

Q2= JAN FEB MAR

Q3= APR MAY JUN

Q4= JUL AUG SEP

BMSN IS RIGHT ON SCHEDULE!! THIS EXPLAINS WHY THE PPS MOVED UP SO SUDDENLY IN JUNE! THIS IS A MAJOR CATLYST!! SECURE YOUR POSITIONS AND ENJOY THE RIDE

NORTH!!

8-K for BMSN (Gene Slilencing Cancer Technology)

On May 1, 2013 Dr. Wei Ping Min ("Min") entered into an agreement ("Agreement") whereby Min assigned to Regen BioPharma Inc. ("Regen") , a wholly owned

subsidiary of Bio-Matrix Scientific Group, Inc.("the Company") , all right, title and interest in US Patent # 8,389,708 as well as all Patent

applications from the same family corresponding to numbers PCT/CA2006/000984, CA2612200 and EP1898936.("Min IP")

http://biz.yahoo.com/e/130612/bmsn8-k.html

Some people here are forgetting about BMSN Business Model! There ultimate end goal is to sell the biotechnology off to Big Pharma! Even though there

business approach is to see a product through Phase 1 & 2 before this happens, this “sale can come at any time!” The more Koos works on the development

of these technologies such as HemaXellerate and the MIN breast cancer vaccine, the more attractive and promising it becomes to big Pharma! As investors

I wouldn't worry about funding because that can come at any moment!

OUR BUSINESS MODEL | REGEN BIOPHARMA, INC.

The Regen BioPharma business model is to take multiple stem cell therapeutics to and through the human "safety and signal of efficacy" stage (Phase I/II

clinical trials), followed by exit. The approach is a highly focused analysis of issued patents in regenerative medicine, identification and acquisition

of undervalued assets that have demonstrated proof of concept, and forming companies around these assets. Having assembled a core infrastructure

specialized in obtaining regulatory approval and executing clinical trials in cell therapy, we aim to act as a "superincubator" that within 1-2 years

grows technologies from laboratory to an asset ready for spin-off or sale to feed the pipeline of Big Pharma.

http://www.regenbiopharma.com/business-model.html

Davis Koos now controls all three entities: Bio-Matrix Scientific Group, Regen BioPharma, Entest BioMedical according to recent developments announced

in the 8-k release! [i]Merging these entities is only logical from a business stand point! [/i]

http://biz.yahoo.com/e/130531/bmsn8-k.html

BMSN has thus far stayed current with their filings and business timeline! Keep in mind investors that these future event are guides! Anything can

happen especially with the FDA at any given notice! Expect a sudden rise in PPS with no reason before that news hits the wire! Given 4 straight weeks of

a down trend BMSN is ready to burst out like a soda bottle being shaking up will all the wacky selling pressure! It will run hard and many will chase

the PPS fast with [b]900%[/b] plus gains! I don't know any investor or trader that likes chasing unless your the savvy one that has been accumulation

during the shouts of doom and gloom ; Sky is falling messages! This is obviously the bottom! I was hoping to get some in the .001s but that [b]will

never happen[/b]! The stock after weeks of churning has now become [b]BULLISH![/b] Mark this post BMSN will run hard!

http://www.americanbulls.com/SignalPage.aspx?...icker=BMSN

I'm very happy with my position! The real question to all the newbies, Are you satified with your share count when this reaches [b].05+[/b]

Last Major PR was featured on NBC website! When FDA news hits the wire it will be covered by everyone!

http://www.nbcnews.com/id/51786808#.UZFZQIy9KSM

[b]PSTI[/b] received orphan drug designation for aplastic anemia which is the same disease HemaXellerate is treating! Its only in due time before

HemaXellerate receives orphan drug designation!

http://regulatoryaffairs.pharmaceutical-busin...tus-220213

Look at the share price the CEO purchased at!! You don't have to worry about shares being dumped on investors with no agenda other than going into a

CEOs pocket, no employees, 1 trillion shares and no agenda!! BMSN is nothing like that! Its the real deal! Most of the shares purchased by the CEOs were

brought well over .50!! Have no worries investors!

http://www.openinsider.com/search?q=bmsn

[i]The key is to be patient and accumulate! That's how the PPS bounced to almost .02 in such a short time! Change your trading strategy on this one!

Everyone need to be on accord here! Unless you like chasing! To each his own...Happy Trading! GLTA!

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Ambassadors Rethink Arbitration's Future

Updated Category News Views 5

Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...

Continue Reading
Arizona Voters Demand Clear Plans for 2026 Election

Updated Category News Views 3

A Shift in Voter Expectations: Clear Actions Needed Arizona voters have spoken, and they aren't looking for the same old political song and dance anymore. They crave something meatier—action, not just words. Heading into the 2026 general election, folks in the Grand Canyon State are demanding concrete solutions and straightforward answers from those who seek to lead...

Continue Reading
Debt Crisis Looms: Social Security at Risk

Updated Category News Views 4

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Continue Reading
Portland Craft Chocolate Fest: Oct. Flavor Fiesta

Updated Category News Views 4

If you're a chocolate lover residing in or around the Portland area, you're in for a treat. The Portland Craft Chocolate Festival is back, running from October 2-4. This festival is not just any community event; it's going to be a massive chocolate bonanza featuring over 45 local chocolate artisans, bakers, and confectioners. And let me tell you, this year they’re...

Continue Reading
Menopause Policy Advocacy Takes Center Stage in DC

Updated Category News Views 5

Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...

Continue Reading
Vetology Reinvents AI Models for Veterinary Radiology

Updated Category News Views 6

Revamping AI in Veterinary Practices Out there in San Diego, Vetology's been rolling up its sleeves and getting down to brass tacks with a complete do-over of their AI classifiers. They’ve rebuilt all 94 of them, every last one, on a brand-new architecture. No small task, this overhaul stretched from June to August and it wasn't just paint and polish but a whole new...

Continue Reading
Bascom's Strategic Play on a Dallas Apartment Deal

Updated Category News Views 8

Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...

Continue Reading
Bellissima Bags Allure Award for Curly Hair Tool

Updated Category News Views 4

Award-Winning Tool Headlines 2026 Beauty Scene There's a shake-up in the world of hair tools, folks. Bellissima's Diffon Supreme has snagged a 2026 Allure Best of Beauty Award for its prowess in taming the curly, wavy, and coily strands we all crave to manage. Performance Meets Innovation in Bellissima's Latest Let's not beat around the bush. The Diffon Supreme's trump...

Continue Reading
Buffett Steps Down, New Faces at Berkshire Hathaway

Updated Category News Views 6

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

Continue Reading
Calavera NY Website Revamp: Gemstone Expansion Hits

Updated Category News Views 5

Calavera New York's Bold Online Makeover When a jewelry brand that's all about slashing retail markups makes a move this big, it's worth a real close-up look. Calavera New York, a name buzzing in the diamond and gemstone scene, just dropped a redesigned website that’s turning more than a few heads. They’re known for cutting out the middleman, a strategy that already...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore How a $100 Investment in Thermo Fisher Could Grow

Updated Category News Views 154

The Growth of Investing in Thermo Fisher Scientific Thermo Fisher Scientific (TMO) has shown remarkable resilience and growth in the financial markets. Over the past decade, the company has consistently outperformed the market, producing an average annual return of around 13.22%. This impressive figure translates into the stock consistently adding value for its investors....

Continue Reading
TÜV Rheinland Partners with SEIA to Enhance Solar Energy Initiatives

Updated Category News Views 88

TÜV Rheinland Partners with SEIA to Enhance Solar Energy Initiatives TÜV Rheinland has made a significant stride by joining the Solar Energy Industries Association (SEIA), highlighting its commitment to the advancement of solar and renewable energy. This collaboration reflects TÜV Rheinland's aim to support clean energy growth and offers world-class services designed...

Continue Reading
Exciting Highlights from the Covenant Health Knoxville Marathon Expo

Updated Category News Views 508

Exciting Highlights from the Covenant Health Knoxville Marathon Expo The Covenant Health Knoxville Marathon has a thrilling announcement for running aficionados and fitness enthusiasts alike. This year's Health & Fitness Expo will feature the renowned two-time Olympian Ryan Hall, adding remarkable value to the event. Ryan Hall is known for his exceptional running prowess...

Continue Reading
Current Investigations into USAP and PDCO Shareholder Rights

Updated Category News Views 154

Understanding the Ongoing Investigations of USAP and PDCO In recent developments, Halper Sadeh LLC, a prominent law firm dedicated to investor rights, has initiated investigations into two significant companies, Universal Stainless & Alloy Products, Inc. (NASDAQ: USAP) and Patterson Companies, Inc. (NASDAQ: PDCO). These investigations address potential violations of...

Continue Reading
FusionTek Enhances IT Solutions with Strategic Acquisition

Updated Category News Views 81

FusionTek's Strategic Growth Through Acquisition Kirkland-based IT managed service provider (MSP) FusionTek has made a notable advancement in its service offerings by acquiring Seattle-based dpe Systems. This acquisition not only enhances FusionTek's capabilities but also marks a significant milestone in their commitment to growth and delivering diverse IT solutions....

Continue Reading